$SWBI
SMITH & WESSON BRANDS, INC.

2024 Q4 Form 10-Q Financial Statement

#000095017024133685 Filed on December 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue $129.7M
YoY Change 3.78%
Cost Of Revenue $95.13M
YoY Change 2.08%
Gross Profit $34.55M
YoY Change 8.75%
Gross Profit Margin 26.64%
Selling, General & Admin $25.35M
YoY Change -3.51%
% of Gross Profit 73.39%
Research & Development $2.221M
YoY Change 28.83%
% of Gross Profit 6.43%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $27.57M
YoY Change -1.51%
Operating Profit $6.972M
YoY Change 85.03%
Interest Expense -$1.419M
YoY Change 119.66%
% of Operating Profit -20.35%
Other Income/Expense, Net -$1.424M
YoY Change 181.98%
Pretax Income $5.548M
YoY Change 70.03%
Income Tax $1.414M
% Of Pretax Income 25.49%
Net Earnings $4.134M
YoY Change 65.49%
Net Earnings / Revenue 3.19%
Basic Earnings Per Share $0.09
Diluted Earnings Per Share $0.09
COMMON SHARES
Basic Shares Outstanding 44.52M
Diluted Shares Outstanding 44.94M

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $39.09M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $52.71M
Other Receivables
Total Short-Term Assets $306.1M
YoY Change 8.6%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $19.02M
YoY Change 0.0%
Intangibles $2.523M
YoY Change -10.63%
Long-Term Investments
YoY Change
Other Assets $8.128M
YoY Change 2.25%
Total Long-Term Assets $281.4M
YoY Change -3.35%
TOTAL ASSETS
Total Short-Term Assets $306.1M
Total Long-Term Assets $281.4M
Total Assets $587.4M
YoY Change 2.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.63M
YoY Change -28.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.18M
YoY Change -15.09%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $7.625M
YoY Change 1.23%
Total Long-Term Liabilities $7.625M
YoY Change 1.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.18M
Total Long-Term Liabilities $7.625M
Total Liabilities $218.4M
YoY Change 9.48%
SHAREHOLDERS EQUITY
Retained Earnings $531.0M
YoY Change 2.57%
Common Stock $293.4M
YoY Change 2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $455.4M
YoY Change 5.75%
Treasury Stock Shares
Shareholders Equity $369.1M
YoY Change
Total Liabilities & Shareholders Equity $587.4M
YoY Change 2.53%

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income $4.134M
YoY Change 65.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001092796
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity File Number
EntityFileNumber
001-31552
dei Entity Registrant Name
EntityRegistrantName
Smith & Wesson Brands, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0543688
dei Entity Address Address Line1
EntityAddressAddressLine1
1852 Proffitt Springs Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Maryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37801
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
331-0852
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SWBI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44002703
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39093000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60839000
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52707000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59071000
CY2024Q4 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
196035000
CY2024Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
160500000
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10112000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4973000
CY2024Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8120000
CY2024Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2495000
CY2024Q4 us-gaap Assets Current
AssetsCurrent
306067000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
287878000
CY2024Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
244452000
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
252633000
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2523000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2598000
CY2024Q4 us-gaap Goodwill
Goodwill
19024000
CY2024Q2 us-gaap Goodwill
Goodwill
19024000
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7249000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7249000
CY2024Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8128000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8614000
CY2024Q4 us-gaap Assets
Assets
587443000
CY2024Q2 us-gaap Assets
Assets
577996000
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31627000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
41831000
CY2024Q4 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
29979000
CY2024Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
26811000
CY2024Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13198000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17147000
CY2024Q4 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
892000
CY2024Q2 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
9098000
CY2024Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1485000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1813000
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77181000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
96700000
CY2024Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
98994000
CY2024Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
39880000
CY2024Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
34578000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
35404000
CY2024Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7625000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7852000
CY2024Q4 us-gaap Liabilities
Liabilities
218378000
CY2024Q2 us-gaap Liabilities
Liabilities
179836000
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75677848
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44219627
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75395490
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45561569
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
76000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2024Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
293362000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
289994000
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
531000000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
540660000
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
73000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
73000
CY2024Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31458221
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29833921
CY2024Q4 us-gaap Treasury Stock Value
TreasuryStockValue
455446000
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
432642000
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
369065000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
398160000
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
587443000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
577996000
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129679000
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124958000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
239201000
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
95133000
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93192000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
159276000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
177034000
CY2024Q4 us-gaap Gross Profit
GrossProfit
34546000
CY2023Q4 us-gaap Gross Profit
GrossProfit
31766000
us-gaap Gross Profit
GrossProfit
58737000
us-gaap Gross Profit
GrossProfit
62167000
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2221000
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1724000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4736000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3522000
CY2024Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9574000
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10952000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19411000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20993000
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15779000
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15322000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29480000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29536000
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
27574000
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
27998000
us-gaap Operating Expenses
OperatingExpenses
53627000
us-gaap Operating Expenses
OperatingExpenses
54051000
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
6972000
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3768000
us-gaap Operating Income Loss
OperatingIncomeLoss
5110000
us-gaap Operating Income Loss
OperatingIncomeLoss
8116000
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
141000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
188000
CY2024Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1419000
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-646000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2152000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-492000
CY2024Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1424000
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-505000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2163000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-304000
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5548000
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3263000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2947000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7812000
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1414000
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
765000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
921000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2196000
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
4134000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2498000
us-gaap Net Income Loss
NetIncomeLoss
2026000
us-gaap Net Income Loss
NetIncomeLoss
5616000
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44523000
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45977000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44922000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46042000
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44935000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46361000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45404000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46458000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
382715000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1484000
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
722000
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
41000
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8294000
CY2023Q4 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
38000
CY2023Q4 us-gaap Dividends
Dividends
5544000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2498000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
373502000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
384623000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2759000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
722000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
806000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8294000
us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
38000
us-gaap Dividends
Dividends
11080000
us-gaap Net Income Loss
NetIncomeLoss
5616000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
373502000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
377986000
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1869000
CY2024Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
749000
CY2024Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
46000
CY2024Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9846000
CY2024Q4 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
14000
CY2024Q4 us-gaap Dividends
Dividends
5767000
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
4134000
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
369065000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
398160000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3722000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
749000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1102000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
22804000
us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
34000
us-gaap Dividends
Dividends
11652000
us-gaap Net Income Loss
NetIncomeLoss
2026000
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
369065000
us-gaap Profit Loss
ProfitLoss
2026000
us-gaap Profit Loss
ProfitLoss
5616000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16261000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17327000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
139000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-682000
swbi Provision For Or Recoveries Of Doubtful Accounts
ProvisionForOrRecoveriesOfDoubtfulAccounts
0
swbi Provision For Or Recoveries Of Doubtful Accounts
ProvisionForOrRecoveriesOfDoubtfulAccounts
-1000
us-gaap Share Based Compensation
ShareBasedCompensation
3722000
us-gaap Share Based Compensation
ShareBasedCompensation
2759000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6364000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4619000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35535000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13827000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5139000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4953000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
5625000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
5178000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10135000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14682000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-3949000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
1324000
swbi Increase Decrease In Deferred Profit Sharing
IncreaseDecreaseInDeferredProfitSharing
-8206000
swbi Increase Decrease In Deferred Profit Sharing
IncreaseDecreaseInDeferredProfitSharing
-6699000
swbi Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
2212000
swbi Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
2859000
swbi Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
-328000
swbi Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
-92000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-486000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-397000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-227000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38212000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37756000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
112000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
125000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
237000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8004000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66983000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7879000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67063000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
60000000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
941000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
swbi Repayments Of Long Term On Finance Lease Obligation
RepaymentsOfLongTermOnFinanceLeaseObligation
89000
swbi Repayments Of Long Term On Finance Lease Obligation
RepaymentsOfLongTermOnFinanceLeaseObligation
681000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22620000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8212000
us-gaap Payments Of Dividends
PaymentsOfDividends
11652000
us-gaap Payments Of Dividends
PaymentsOfDividends
11080000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
749000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
722000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1102000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
806000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24345000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19943000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21746000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9364000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60839000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53556000
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39093000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44192000
us-gaap Interest Paid Net
InterestPaidNet
2353000
us-gaap Interest Paid Net
InterestPaidNet
1725000
us-gaap Income Taxes Paid
IncomeTaxesPaid
6785000
us-gaap Income Taxes Paid
IncomeTaxesPaid
7353000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2394000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8826000
swbi Capital Lease Included In Accrued Expenses And Finance Lease Payable
CapitalLeaseIncludedInAccruedExpensesAndFinanceLeasePayable
528000
swbi Capital Lease Included In Accrued Expenses And Finance Lease Payable
CapitalLeaseIncludedInAccruedExpensesAndFinanceLeasePayable
694000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1) Organization:</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are one of the world’s leading manufacturers and designers of firearms. We manufacture a wide array of handguns (including revolvers and pistols), long guns (including modern sporting rifles, pistol caliber carbines, and lever action rifles), handcuffs, firearm suppressors, and other firearm-related products for sale to a wide variety of customers, including firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement and security agencies and officers, and military agencies in the United States and throughout the world. We sell our products under the Smith &amp; Wesson and Gemtech brands. We manufacture our products at our facilities in Springfield, Massachusetts; Houlton, Maine; </span><span style="color:#161616;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deep River, Connecticut;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and Maryville, Tennessee. We also sell our manufacturing services to other businesses to attempt to level-load our factories. We sell those services under our Smith &amp; Wesson and Smith &amp; Wesson Precision Components brands. During fiscal 2024, we began manufacturing and distribution activities from our new Maryville facility. During the quarter ended October 31, 2024, we discontinued operations at our Connecticut facility in anticipation of vacating the premises in December 2024. See Note 8 — </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commitments and Contingencies </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and Note 9 — </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restructuring</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for more information.</span></p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2) Basis of Presentation:</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interim Financial Information –</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The condensed consolidated balance sheet as of October 31, 2024, the condensed consolidated statements of income for the three and six months ended October 31, 2024 and 2023, the condensed consolidated statements of changes in stockholders’ equity for the three and six months ended October 31, 2024 and 2023, and the condensed consolidated statements of cash flows for the six months ended October 31, 2024 and 2023 have been prepared by us without audit. In our opinion, all adjustments, which include only normal recurring adjustments necessary to fairly present the financial position, results of operations, changes in stockholders’ equity, and cash flows for the three and six months ended October 31, 2024 and for the periods presented, have been included. All intercompany transactions have been eliminated in consolidation. The consolidated balance sheet as of April 30, 2024 has been derived from our audited consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States, or GAAP, have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Fiscal 2024 Form 10-K. The results of operations for the three and six months ended October 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">may</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">not be indicative of the results that may be expected for the fiscal year ending April 30, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or any other period.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recently Issued Accounting Standards –</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update ("ASU") No. 2023-07, Improvements to Reportable Segment Disclosures, which requires incremental disclosures about an entity’s reportable segments but does not change the definition of a segment or the guidance for determining reportable segments. The new guidance requires disclosure of significant segment expenses that are (1) regularly provided to (or easily computed from information regularly provided to) the chief operating decision maker and (2) included in the reported measure of segment profit or loss. The new standard also allows companies to disclose multiple measures of segment profit or loss if those measures are used to assess performance and allocate resources. This update is effective for fiscal years beginning after December 15, 2023, and should be adopted retrospectively unless impracticable. This update will be effective for us, beginning with our Annual Report on Form 10-K for the fiscal year ending April 30, 2025 and interim periods thereafter. We are currently evaluating the impact, if any, that the adoption of this standard will have on financial disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures, which requires entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and provide more details about the reconciling items in some categories if items meet a quantitative threshold. Entities would have to provide qualitative disclosures about the new categories. The guidance will require all entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods, and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. Entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The guidance is effective for annual periods beginning after December 15, 2024, or fiscal 2026 for us. We are currently evaluating the impact, if any, that the adoption of this standard will have on financial disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which requires entities to disclose, in the notes to financial statements, specified information about certain costs and expenses included in each relevant expense caption presented on the face of the income statement. Entities will also be required to disclose qualitative descriptions of the amounts</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">remaining in relevant expense captions that are not separately disaggregated quantitatively. Entities will need to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. Entities are required to apply the guidance prospectively, with the option to apply it retrospectively. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The guidance is effective for annual periods beginning after December 15, 2026, or fiscal 2028 for us. We are currently evaluating the impact that the adoption of this standard will have on financial disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div>
CY2024Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
119225000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
83337000
CY2024Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
55870000
CY2024Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
56282000
CY2024Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8890000
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8033000
CY2024Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12050000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12848000
CY2024Q4 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
196035000
CY2024Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
160500000
CY2024Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5603000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4925000
CY2024Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
5479000
CY2024Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
5838000
CY2024Q4 swbi Accrued Settlement
AccruedSettlement
3270000
CY2024Q2 swbi Accrued Settlement
AccruedSettlement
3200000
CY2024Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2752000
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2742000
CY2024Q4 swbi Accrued Distributor Incentives Current
AccruedDistributorIncentivesCurrent
2600000
CY2024Q2 swbi Accrued Distributor Incentives Current
AccruedDistributorIncentivesCurrent
1687000
CY2024Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1631000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1564000
CY2024Q4 swbi Accrued Rebates And Promotions Current
AccruedRebatesAndPromotionsCurrent
1472000
CY2024Q2 swbi Accrued Rebates And Promotions Current
AccruedRebatesAndPromotionsCurrent
1485000
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
430000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
947000
CY2024Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6742000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4423000
CY2024Q4 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
29979000
CY2024Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
26811000
CY2024Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4134000
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44523000
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2498000
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45977000
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2024Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
412000
CY2024Q4 swbi Earnings Per Share Effect Of Dilutive Stock Award
EarningsPerShareEffectOfDilutiveStockAward
0
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
384000
CY2023Q4 swbi Earnings Per Share Effect Of Dilutive Stock Award
EarningsPerShareEffectOfDilutiveStockAward
0
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
4134000
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44935000
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2498000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46361000
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2026000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44922000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5616000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46042000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
482000
swbi Earnings Per Share Effect Of Dilutive Stock Award
EarningsPerShareEffectOfDilutiveStockAward
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
416000
swbi Earnings Per Share Effect Of Dilutive Stock Award
EarningsPerShareEffectOfDilutiveStockAward
0
us-gaap Net Income Loss
NetIncomeLoss
2026000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45404000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Net Income Loss
NetIncomeLoss
5616000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46458000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000
swbi Share Based Compensation Arrangement By Share Based Payment Award Performance Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod
P3Y
CY2018Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
18600000
swbi Number Of Product Liability Cases
NumberOfProductLiabilityCases
2
swbi Number Of Other Product Liability Claims
NumberOfOtherProductLiabilityClaims
7
swbi Year Of Other Product Liability Claim
YearOfOtherProductLiabilityClaim
December 2019
CY2024Q4 swbi Commitments Estimated Capital Expenditure On New Facility
CommitmentsEstimatedCapitalExpenditureOnNewFacility
120000000
CY2023Q1 us-gaap Construction Contract Cost Progress Payment Offset
ConstructionContractCostProgressPaymentOffset
114500000
CY2024Q4 swbi Cost Of Machinery And Equipment
CostOfMachineryAndEquipment
165000000
CY2024Q4 swbi Cost Of Machinery And Equipment Due Remainder Of Fiscal Year
CostOfMachineryAndEquipmentDueRemainderOfFiscalYear
170000000
swbi Capital Expenditures Incurred
CapitalExpendituresIncurred
158000000
CY2024Q4 us-gaap Restructuring Charges
RestructuringCharges
488000
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
2100000
us-gaap Restructuring Charges
RestructuringCharges
428000
us-gaap Restructuring Charges
RestructuringCharges
6000000
CY2024Q4 us-gaap Restructuring Charges
RestructuringCharges
488000
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
2061000
us-gaap Restructuring Charges
RestructuringCharges
428000
us-gaap Restructuring Charges
RestructuringCharges
5973000
CY2024Q4 us-gaap Restructuring Charges
RestructuringCharges
488000
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
2061000
us-gaap Restructuring Charges
RestructuringCharges
428000
us-gaap Restructuring Charges
RestructuringCharges
5973000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
6355000
us-gaap Restructuring Costs
RestructuringCosts
-348000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2125000
CY2024Q4 us-gaap Restructuring Reserve
RestructuringReserve
3882000

Files In Submission

Name View Source Status
0000950170-24-133685-index-headers.html Edgar Link pending
0000950170-24-133685-index.html Edgar Link pending
0000950170-24-133685.txt Edgar Link pending
0000950170-24-133685-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img126818207_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
swbi-20241031.htm Edgar Link pending
swbi-20241031.xsd Edgar Link pending
swbi-ex31_1.htm Edgar Link pending
swbi-ex31_2.htm Edgar Link pending
swbi-ex32_1.htm Edgar Link pending
swbi-ex32_2.htm Edgar Link pending
swbi-20241031_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable